Nebula Research & Development LLC
- SEC CIK
- 0001792635
- Latest filing
- May 15, 2026
MDGL holding history
Madrigal Pharmaceuticals, Inc. in every 13F filed by Nebula Research & Development LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MDGL overviewAll 13F holders of MDGLFull Q1 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −6,552−100.0% | Sold out | Holders |
| Q3 2023 | 6,552 | $956.9K | 0.5% | +4,082+165.3% | Added | Holders |
| Q2 2023 | 2,470 | $570.6K | 0.4% | +1,335+117.6% | Added | Holders |
| Q1 2023 | 1,135 | $275.0K | 0.5% | – | No prior filing | Holders |